Article
Pharmacogenetics of warfarin: current status and future challenges.
The pharmacogenomics journal - 1 Apr 2007
Wadelius M, Pirmohamed M
Abstract excerpt
Warfarin is an anticoagulant that is difficult to use because of the wide variation in dose required to achieve a therapeutic effect, and the risk of serious bleeding. Warfarin acts by interfering with the recycling of vitamin K in the liver, which leads to reduced activation of several clotting factors. Thirty genes that may be involved in the biotransformation and mode of action of warfarin are discussed in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
